Have a personal or library account? Click to login
Proposed Strategies to Improve Adult Asthma Management in Egypt: Expert Review and Recommendations Cover

Proposed Strategies to Improve Adult Asthma Management in Egypt: Expert Review and Recommendations

Annals of Global Health
Volume 88 (2022): Issue 1
By: Hossam Hosny,  Ashraf Madkour,  Mohamed Hantera,  Mohamed Dahy,  Faten Emara,  Maha Ibrahim and  Tarek Safwat  
Open Access
|Nov 2022

References

  1. 1Vos T, Abajobir AA, Abbafati C, Abbas KM, Abate KH, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100): 1211–1259.
    Back to article
  2. 2Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017; 5(9): 691–706.
    Back to article
  3. 3World Health Organization. Asthma Key Facts. WHO Tech Rep Ser. 2020.
    Back to article
  4. 4Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, et al. Prevalence of asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program. BMC Pulm Med. 2018; 18(1): 68. DOI: 10.1186/s12890-018-0621-9
    Back to article
  5. 5Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J. 1999; 14(4): 951–957. DOI: 10.1034/j.1399-3003.1999.14d37.x
    Back to article
  6. 6Global Initiative for Asthma. GINA Report, Global Strategy for Asthma Management and Prevention. GINA. 2021.
    Back to article
  7. 7Beaney T, Salman D, Samee T, Mak V. Assessment and management of adults with asthma during the COVID-19 pandemic. BMJ. 2020; 369: m2092. DOI: 10.1136/bmj.m2092
    Back to article
  8. 8Bassam M, Behbehani N, Farouk H, Alsayed M, Montestruc F, Al-Jahdali H, et al. Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study. Respir Med. 2021; 176: 106244. DOI: 10.1016/j.rmed.2020.106244
    Back to article
  9. 9Tarraf H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, Haouichat H, Khassawneh B, et al. Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study. Respir Med. 2018; 138: 64–73. DOI: 10.1016/j.rmed.2018.03.024
    Back to article
  10. 10Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and strategies in guideline implementation—A scoping review. Healthc (Basel, Switzerland). 2016; 4(3). DOI: 10.3390/healthcare4030036
    Back to article
  11. 11Dusser D, Montani D, Chanez P, de Blic J, Delacourt C, Deschildre A, et al. Mild asthma: An expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy. 2007; 62(6): 591–604. DOI: 10.1111/j.1398-9995.2007.01394.x
    Back to article
  12. 12O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: Time for a new approach? Eur Respir J. 2017; 50(3). DOI: 10.1183/13993003.01103-2017
    Back to article
  13. 13Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018; 378(20): 1877–1887. DOI: 10.1056/NEJMoa1715275
    Back to article
  14. 14McIvor A, Kaplan A. A call to action for improving clinical outcomes in patients with asthma. NPJ Prim Care Respir Med. 2020; 30(1): 54. DOI: 10.1038/s41533-020-00211-x
    Back to article
  15. 15Zar HJ, Levin ME. Challenges in treating pediatric asthma in developing countries. Paediatr Drugs. 2012; 14(6): 353–359. DOI: 10.2165/11597420-000000000-00000
    Back to article
  16. 16Gerald JK, Carr TF, Wei CY, Holbrook JT, Gerald LB. Albuterol overuse: A marker of psychological distress? J Allergy Clin Immunol Pract. 2015. DOI: 10.1016/j.jaip.2015.06.021
    Back to article
  17. 17Yang JF, Chaudhuri R, Thomson NC, Ramparsad N, O’Pray H, Barclay S, et al. Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations. NPJ Prim Care Respir Med. 2018; 28(1): 35. DOI: 10.1038/s41533-018-0103-9
    Back to article
  18. 18Uzaslan E, Mahboub B, Beji M, Nejjari C, Tageldin MA, Khan JA, et al. The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: Results of the BREATHE study. Respir Med. 2012; 106(Suppl 2): S45–S59. DOI: 10.1016/S0954-6111(12)70014-8
    Back to article
  19. 19Tageldin MA, Nafti S, Khan JA, Nejjari C, Beji M, Mahboub B, et al. Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012; 106(Suppl 2): S25–S32. DOI: 10.1016/S0954-6111(12)70012-4
    Back to article
  20. 20Rees J. Asthma control in adults. BMJ. 2006; 332(7544): 767–771. DOI: 10.1136/bmj.332.7544.767
    Back to article
  21. 21Braman SS. The global burden of asthma. Chest. 2006; 130(1 Suppl): 4S–12S. DOI: 10.1378/chest.130.1_suppl.4S
    Back to article
  22. 22Patel SP, Järvelin M-R, Little MP. Systematic review of worldwide variations of the prevalence of wheezing symptoms in children. Environ Health. 2008; 7: 57. DOI: 10.1186/1476-069X-7-57
    Back to article
  23. 23Baïz N, Annesi-Maesano I. Is the asthma epidemic still ascending? Clin Chest Med. 2012; 33(3): 419–429. DOI: 10.1016/j.ccm.2012.06.001
    Back to article
  24. 24Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007; 120(5): 1031–1035. DOI: 10.1016/j.jaci.2007.08.028
    Back to article
  25. 25José BP de S, Camargos PAM, Cruz Filho ÁAS da, Corrêa R de A. Diagnostic accuracy of respiratory diseases in primary health units. Rev Assoc Med Bras. 2014; 60(6): 599–612. DOI: 10.1590/1806-9282.60.06.021
    Back to article
  26. 26Enarson DA, Vedal S, Schulzer M, Dybuncio A, Chan-Yeung M. Asthma, asthmalike symptoms, chronic bronchitis, and the degree of bronchial hyperresponsiveness in epidemiologic surveys. Am Rev Respir. 1987; 136(3): 613–617. DOI: 10.1164/ajrccm/136.3.613
    Back to article
  27. 27Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, et al. The Severe Asthma Network in Italy: Findings and perspectives. J Allergy Clin Immunol Pract. 2019; 7(5): 1462–1468.
    Back to article
  28. 28Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017; 3(1): 1. Retrieved from http://asthmarp.biomedcentral.com/articles/10.1186/s40733-016-0029-3. DOI: 10.1186/s40733-016-0029-3
    Back to article
  29. 29Loftus PA, Wise SK. Epidemiology and economic burden of asthma. Int Forum Allergy Rhinol. 2015; 5(Suppl 1): S7–S10. DOI: 10.1002/alr.21547
    Back to article
  30. 30Stanford RH, Shah MB, D’Souza AO, Dhamane AD, Schatz M. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Ann allergy, asthma Immunol Off Publ Am Coll Allergy, Asthma, Immunol. 2012; 109(6): 403–407. DOI: 10.1016/j.anai.2012.08.014
    Back to article
  31. 31Bårnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: Current status and future perspectives. Respir Care. 2015; 60(3): 455–468. DOI: 10.4187/respcare.03200
    Back to article
  32. 32Sulaiman I, Seheult J, MacHale E, D’Arcy S, Boland F, McCrory K, et al. Irregular and ineffective: A quantitative observational study of the time and technique of inhaler use. J Allergy Clin Immunol Pract. 2016; 4(5): 900–909, e2. DOI: 10.1016/j.jaip.2016.07.009
    Back to article
  33. 33Reddel HK, Bateman ED, Becker A, Boulet L-P, Cruz AA, Drazen JM, et al. A summary of the new GINA strategy: A roadmap to asthma control. Eur Respir J. 2015; 46(3): 622–639. DOI: 10.1183/13993003.00853-2015
    Back to article
  34. 34Ajami S, Bagheri-Tadi T. Barriers for adopting electronic health records (EHRs) by physicians. Acta Inform Medica J Soc Med Informatics Bosnia Herzegovina Cas Drus za Med Inform BiH. 2013; 21(2): 129–134. DOI: 10.5455/aim.2013.21.129-134
    Back to article
  35. 35World Health Organization. Transforming and scaling up health professionals’ education and training. WHO Tech Rep Ser. 2013.
    Back to article
  36. 36Cloutier MM, Salo PM, Akinbami LJ, Cohn RD, Wilkerson JC, Diette GB, et al. Clinician agreement, self-efficacy, and adherence with the guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol Pract. 2018; 6(3): 886–894, e4. DOI: 10.1016/j.jaip.2018.01.018
    Back to article
  37. 37Kavanagh J, Jackson DJ, Kent BD. Over- and under-diagnosis in asthma. Breathe (Sheffield, England). 2019; 15(1): e20–e27. DOI: 10.1183/20734735.0362-2018
    Back to article
  38. 38Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: The REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014; 24: 14009. DOI: 10.1038/npjpcrm.2014.9
    Back to article
  39. 39Partridge MR, van der Molen T, Myrseth S-E, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE study. BMC Pulm Med. 2006; 6: 13. DOI: 10.1186/1471-2466-6-13
    Back to article
  40. 40Kaplan A, Mitchell PD, Cave AJ, Gagnon R, Foran V, Ellis AK. Effective asthma management: Is it time to let the AIR out of SABA? J Clin Med. 2020; 9(4). DOI: 10.3390/jcm9040921
    Back to article
  41. 41Azzi EA, Kritikos V, Peters MJ, Price DB, Srour P, Cvetkovski B, et al. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta(2) agonists: An Australian community pharmacy-based survey. BMJ Open. 2019; 9(8): e028995. DOI: 10.1136/bmjopen-2019-028995
    Back to article
  42. 42Silver HS, Blanchette CM, Kamble S, Petersen H, Letter MA, Meddis D, et al. Relationship between short-acting β2-adrenergic agonist use and healthcare costs. Am J Manag Care. 2011; 17(1): 19–27.
    Back to article
  43. 43Bethesda, MD. National Heart, Lung and Blood Institute. Guidelines for the diagnosis and management of asthma 2007 (EPR-3). NIH Publ no. 08–4051. 2007.
    Back to article
  44. 44Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013; 8(12): e80633. DOI: 10.1371/journal.pone.0080633
    Back to article
  45. 45Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, Michael White C, Lazarus SC, et al. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: A systematic review and meta-analysis. Journal of the American Medical Association. 2018. DOI: 10.1001/jama.2018.2769
    Back to article
  46. 46Kupczyk M, Haahtela T, Cruz AA, Kuna P. Reduction of asthma burden is possible through National Asthma Plans. Allergy. 2010; 65(4): 415–419. DOI: 10.1111/j.1398-9995.2009.02265.x
    Back to article
  47. 47Global Initiative for Asthma. GINA report 2018. 2018.
    Back to article
  48. 48Elsisi GH, Carapinha J, Amin W, Thabet E, Elafify S, Amin M, et al. A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt. J Med Econ. 2019; 22(10): 1047–154. DOI: 10.1080/13696998.2019.1642899
    Back to article
  49. 49Indicators WB development. Literacy rate, adult total (% of people ages 15 and above)—Egypt, Arab Rep. worldbank.
    Back to article
  50. 50Bateman ED, Reddel HK, Eriksson G, Peterson S, Ostlund O, Sears MR, et al. Overall asthma control: The relationship between current control and future risk. J Allergy Clin Immunol. 2010; 125(3): 600–608, 608.e1–e6. DOI: 10.1016/j.jaci.2009.11.033
    Back to article
  51. 51Weiler JM, Brannan JD, Randolph CC, Hallstrand TS, Parsons J, Silvers W, et al. Exercise-induced bronchoconstriction update—2016. J Allergy Clin Immunol. 2016; 138(5): 1292–1295, e36. DOI: 10.1016/j.jaci.2016.05.029
    Back to article
DOI: https://doi.org/10.5334/aogh.3782 | Journal eISSN: 2214-9996
Journal RSS Feed
Language: English
Submitted on: Mar 17, 2022
Accepted on: Aug 31, 2022
Published on: Nov 17, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Asthma,
inflammatory,
bronchitis,
smoke,
Egypt

© 2022 Hossam Hosny, Ashraf Madkour, Mohamed Hantera, Mohamed Dahy, Faten Emara, Maha Ibrahim, Tarek Safwat, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 88 (2022): Issue 1Next article